Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions. - Major A; Yu J; Shukla N; Che Y; Karrison TG; Treitman R; Kamdar MK; Haverkos BM; Godfrey J; Babcook MA; Voorhees TJ; Carlson S; et al. (Blood advances, 2023)